The essentials
Former NFL players Favre and Green diagnosed with Parkinson's; NFL players four times more likely to develop neurodegenerative diseases.
Brett Favre received a Parkinson's disease diagnosis in September 2024, followed by Ahman Green's early-onset Parkinson's diagnosis in January 2025. Green, the Green Bay Packers' all-time leading rusher with 8,322 yards, joins Favre among high-profile former players facing the neurodegenerative condition.
Research indicates NFL players are four times more likely to die from neurodegenerative diseases than the general population. The pattern of diagnoses among former players raises questions about potential occupational factors, though specific causation remains under investigation. Both athletes' cases contribute to ongoing discussions about player health outcomes and long-term consequences of professional football careers.
Other ways to read this story.
Alternative framings generated by SigNews. These are not independent sources or attributed quotations.
Cluster of Diagnoses Highlights Neurodegenerative Disease Pattern in Former Players
Recent Parkinson's diagnoses among former NFL players underscore epidemiological findings that NFL players face significantly elevated mortality risk from neurodegenerative diseases. The consecutive diagnoses of Favre and Green suggest a broader health pattern affecting the player population, warranting clinical attention and further research into contributing factors.
Hall of Famer and All-Time Rusher Navigate Parkinson's After Playing Careers
Two of the Green Bay Packers' most significant contributors—Hall of Famer Brett Favre and all-time leading rusher Ahman Green with 8,322 yards—now face Parkinson's disease diagnoses. Their cases bring public visibility to neurodegenerative health challenges affecting former professional football players years after retirement.